SCHEMBL5015213

SCHEMBL5015213

CNC(C(=O)Oc1cc(OC)c(OC)c(OC)c1)C(C(=O)OC(CCc1cccnc1)CCc1cccnc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 6/20 0.45
ABCC1 P33527 1/20 0.41
FKBP4 Q02790 1/20 0.41
FKBP5 Q13451 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 3/20 0.40
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
G6PD P11413 1/20 0.38
GFER P55789 1/20 0.38
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
ABCB1 P08183 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5015211 0.95 FKBP1A (0.48) FKBP1AABCC1FKBP4FKBP5ALDH1A1
SCHEMBL3672286 0.77 KMT2A (0.44) ALDH1A1KDM4EKMT2ALMNAGFER
SCHEMBL3675773 0.71 FKBP1A (0.46) FKBP1AABCC1FKBP4FKBP5ALDH1A1
SCHEMBL9190506 0.67 ALDH1A1 (0.55) ALDH1A1HPGDKDM4EPOLBKMT2A
SCHEMBL3670538 0.66 FKBP1A (0.49) FKBP1AABCC1FKBP4FKBP5ALDH1A1
SCHEMBL3672384 0.65 FKBP1A (0.78) FKBP1AABCC1FKBP4FKBP5
SCHEMBL15162579 0.63 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EPOLBKMT2A
SCHEMBL29644831 0.63 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EPOLBKMT2A
SCHEMBL6158967 0.63 PTAFR (0.52) ALDH1A1HPGDKDM4EPOLBKMT2A
SCHEMBL22444599 0.62 TBXAS1 (0.51) KDM4EKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1138673-B1 Novel carbamates and ureas as modifiers of multi-drug resistance VERTEX PHARMA (US) 2008-08-06 EP claimed
EP-1138673-A2 Novel carbamates and ureas as modifiers of multi-drug resistance Vertex Pharmaceuticals Incorporated (US) 2001-10-04 EP claimed
EP-0754176-A1 NOVEL CARBAMATES AND UREAS AS MODIFIERS OF MULTI-DRUG RESISTANCE Vertex Pharmaceuticals Incorporated (US) 1997-01-22 EP claimed
WO-1995026337-A1 NOVEL CARBAMATES AND UREAS AS MODIFIERS OF MULTI-DRUG RESISTANCE VERTEX PHARMACEUTICALS INCORPORATED (US) 1995-10-05 WO claimed
EP-1138673-B1 Novel carbamates and ureas as modifiers of multi-drug resistance VERTEX PHARMA (US) 2008-08-06 EP disclosed
EP-1666053-A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors Vertex Pharmceuticals Incorporated (US) 2006-06-07 EP disclosed
EP-0754176-B1 NOVEL CARBAMATES AND UREAS AS MODIFIERS OF MULTI-DRUG RESISTANCE VERTEX PHARMA (US) 2001-12-05 EP disclosed
EP-1138673-A2 Novel carbamates and ureas as modifiers of multi-drug resistance Vertex Pharmaceuticals Incorporated (US) 2001-10-04 EP disclosed
US-5780484-A Methods for stimulating neurite growth with piperidine compounds VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-07-14 US disclosed
US-5744485-A INCREASE SENSITIVITY OF CELLS; CANCER VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-04-28 US disclosed